# Single Dose PG102 in Patients With Active Psoriatic Arthritis

> **NCT00787137** · PHASE1 · TERMINATED · sponsor: **PanGenetics UK Limited** · enrollment: 17 (actual)

## Conditions studied

- Arthritis, Psoriatic

## Interventions

- **DRUG:** PG102
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT00787137
- **Lead sponsor:** PanGenetics UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** poor recruitment
- **Last updated:** 2010-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787137, "Single Dose PG102 in Patients With Active Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00787137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*